What are the barriers to effective clinical trials?
Clinical trials are essential for developing new cancer treatments, but they face several hurdles. Patient recruitment is a significant challenge, often due to stringent eligibility criteria and a lack of awareness. Ensuring diversity in clinical trials to make the results more generalizable is another issue. Additionally, the high cost and lengthy duration of trials can be prohibitive. Adaptive trial designs and the use of real-world evidence can help to make trials more efficient and reflective of broader patient populations.
